Skip to main content
NIH funding notice RFA-DA-21-032

Digital Technologies to Address the Social Determinants of Health in Context of Substance Use Disorders (SUD) (R43/R44 Clinical Trial Optional)

Closed on February 26, 2021.

Posted
December 22, 2020
Close date
February 26, 2021
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $425,535 in first-year total cost, median $425,535.

Most frequent study sections

  1. Special Emphasis Panel[ZDA1 TXT-V (03)]1

Most frequent institutions

  1. MEDICAL INNOVATORS COMPANY, LLC1
Competing awards under RFA-DA-21-032 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2021A Software Product That Empowers Individuals Affected By Substance Use Disorders and Their Care Teams with Health and Social Resources2R44DA051063-02LEE, TOMMEDICAL INNOVATORS COMPANY, LLC, TX$425,535ZDA1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

RFA-DA-21-032: Digital Technologies to Address the Social Determinants of Health in Context of Substance Use Disorders (SUD) (R43/R44 Clinical Trial Optional) | ScienceDex | ConductScience